PMID- 19032678 OWN - NLM STAT- MEDLINE DCOM- 20081223 LR - 20211203 IS - 1755-3768 (Electronic) IS - 1755-375X (Linking) VI - 86 Thesis 4 DP - 2008 Nov TI - Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications. PG - 20-5 LID - 10.1111/j.1755-3768.2008.01182.x [doi] AB - PURPOSE: Uveal melanoma disseminates preferentially to the liver. The mechanism for this homing is largely unknown, but growth factors synthesized in the liver may be involved. The present study was undertaken to investigate the possible relationship between cell surface receptors for two such growth factors: the c-Met proto-oncogene, which constitutes the receptor for hepatocyte growth factor/scatter factor (HGF/SF), and the insulin-like growth factor 1 receptor (IGF-1R). Their role as a prognostic factor was also clarified. METHODS: Paraffin-embedded tumor specimens from 132 patients with primary uveal melanoma were analyzed by using well-established specific antibodies against c-Met and IGF-1R. The intercorrelation of receptor expression and association with melanoma-related survival of patients were determined by univariate and multivariate analyses. RESULTS: Whereas the expression of both IGF-1R and c-Met was significantly associated with melanoma-specific mortality by univariate analysis (p = 0.004 and p = 0.007, respectively) only IGF-1R showed independent prognostic value by multivariate analysis, p = 0.004. The prognostic value of IGF-1R was stronger than such currently used prognostic parameters as tumor cell type and tumor diameter (p = 0.021 and p = 0.026, respectively). The expression patterns of the two growth factors receptors were weakly intercorrelated. CONCLUSIONS: In conclusion, the data suggest that the receptors for IGF-1 and HGF/SF may play a role in the spread of uveal melanoma and its affinity to the liver. The strong correlation between IGF-1R expression and melanoma-specific mortality points to the use of IGF-1R as a prognostic tool [Economou MA, All-Ericsson C, Bykov V, Girnita L, Bartolazzi A, Larsson O & Seregard S (2005): Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications. FAU - Economou, Mario A AU - Economou MA AD - Cellular and Molecular Tumor Pathology, Department of Oncology and Pathology, Karolinska Hospital, Stockholm, Sweden. FAU - All-Ericsson, Charlotta AU - All-Ericsson C FAU - Bykov, Vladimir AU - Bykov V FAU - Girnita, Leonard AU - Girnita L FAU - Bartolazzi, Armando AU - Bartolazzi A FAU - Larsson, Olle AU - Larsson O FAU - Seregard, Stefan AU - Seregard S LA - eng PT - Journal Article PL - England TA - Acta Ophthalmol JT - Acta ophthalmologica JID - 101468102 RN - 0 (MAS1 protein, human) RN - 0 (Proto-Oncogene Mas) RN - EC 2.7.10.1 (Proto-Oncogene Proteins c-met) RN - EC 2.7.10.1 (Receptor, IGF Type 1) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Female MH - Humans MH - Immunologic Techniques MH - Kaplan-Meier Estimate MH - Liver/*metabolism MH - Liver Neoplasms/secondary MH - Male MH - Melanoma/*metabolism/mortality/secondary MH - Middle Aged MH - Multivariate Analysis MH - Prognosis MH - Proportional Hazards Models MH - Proto-Oncogene Mas MH - Proto-Oncogene Proteins c-met/biosynthesis/*metabolism MH - Receptor, IGF Type 1/biosynthesis/*metabolism MH - Staining and Labeling MH - Uveal Neoplasms/*metabolism/mortality EDAT- 2008/11/27 09:00 MHDA- 2008/12/24 09:00 CRDT- 2008/11/27 09:00 PHST- 2008/11/27 09:00 [pubmed] PHST- 2008/12/24 09:00 [medline] PHST- 2008/11/27 09:00 [entrez] AID - AOS1182 [pii] AID - 10.1111/j.1755-3768.2008.01182.x [doi] PST - ppublish SO - Acta Ophthalmol. 2008 Nov;86 Thesis 4:20-5. doi: 10.1111/j.1755-3768.2008.01182.x.